AQR Capital Management
BCAB icon

AQR Capital Management’s BioAtla BCAB Stock Holding History

AQR Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,723
Closed -$872K – 2765
2024
Q2 		$872K Buy
+12,723
New +$1.51M ﹤0.01% 1814
2022
Q3 		– Sell
-683
Closed -$97K – 2199
2022
Q2 		$97K Buy
+683
New +$109K ﹤0.01% 2092

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AQR Capital Management's BCAB Position: Q3 2024 in Review

AQR Capital Management sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 12,723 shares — an estimated $872K sold.

AQR Capital Management first reported a position in BCAB in Q2 2022 and held it in 2 quarters. The position peaked at $872K in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • AQR Capital Management reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • AQR Capital Management sold 12,723 BioAtla shares in Q3 2024, an estimated $872K.
  • AQR Capital Management first reported a position in BioAtla in Q2 2022 and held it in 2 quarters.
  • AQR Capital Management's BioAtla position peaked at $872K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.